Mark Harbinson

Mark Harbinson is a Clinical Professor at Queen's University Belfast's School of Medicine, Dentistry and Biomedical Sciences, where he leads research in cardiovascular diagnostics through the Centre for Vision and Vascular Science. His laboratory focuses on imaging and biomarker technologies to study pulmonary arterial hypertension and chemotherapy-induced cardiac dysfunction.

Research domains include:

• Cardiovascular biomarker discovery and validation
• Radiation cardiotoxicity mechanisms in oncology
• Therapeutic outcome prediction models
• Cardiac remodeling processes

Recent publications (2024-2025) demonstrate strong focus on:

• Cardio-oncology interactions in lung cancer treatment
• Radiation therapy safety optimization
• Medical education methodology validation

Professional service includes:

• Chair, British Nuclear Cardiology Society (2005-2007)
• Member, American Society of Nuclear Cardiology (2008-2010)
• Co-organizer of WWIEM-Cardiology Joint Research Symposium (2019)

Research leadership includes co-investigator role on NIHR-funded project 'Evaluation of novel prognostic risk indicators for cardiovascular disease' (2014-2016). Maintains active clinical research collaborations across cardiology and oncology disciplines.